U.S. regulators are strictly limiting who can receive Johnson & Johnson’s COVID-19 vaccine due to a rare but serious risk of blood clots
Related posts
-
America reaches Election Day and a stark choice between Trump and Harris
A presidential campaign marked by upheaval and rancor approached its finale on Election Day as Americans... -
Bears coaches feel heat, but don’t forget about bad drafts of past
The Bears season is losing steam quickly, but Sunday’s loss in Arizona was another reminder that... -
Who had the area’s top performances in the first round of the IHSA football playoffs?
With the first round of the IHSA football playoffs in the books, it's once again time...